Optimal timing of thrombolytic therapy in acute ischaemic stroke. [electronic resource]
Producer: 20020712Description: 213-8 p. digitalISSN:- 1172-7047
- Ancrod -- adverse effects
- Clinical Trials as Topic
- Fibrinolytic Agents -- adverse effects
- Humans
- Infusions, Intra-Arterial
- Plasminogen Activators -- adverse effects
- Streptokinase -- adverse effects
- Stroke -- drug therapy
- Thrombolytic Therapy -- adverse effects
- Time Factors
- Tissue Plasminogen Activator -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.